Wuhan Thalys Med Tech Co Ltd (603716) — Free Cash Flow Generation Index
Wuhan Thalys Med Tech Co Ltd (603716) has a Free Cash Flow Generation Index of 0.97x as of September 2025. Free cash flow of CN¥53.00 Million represents 1% of operating cash flow (CN¥54.57 Million). Explore how much does Wuhan Thalys Med Tech Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Wuhan Thalys Med Tech Co Ltd Free Cash Flow Generation Index (2012–2024)
Historical FCF Generation Index trend for Wuhan Thalys Med Tech Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see 603716 operating cash flow.
Annual Free Cash Flow Generation for Wuhan Thalys Med Tech Co Ltd (2012–2024)
Year-by-year Free Cash Flow Generation Index for Wuhan Thalys Med Tech Co Ltd. Check 603716 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.77x | CN¥76.39 Million | CN¥99.60 Million | CN¥23.21 Million | ▲ +13.5% |
| 2023 | 0.68x | CN¥85.06 Million | CN¥125.89 Million | CN¥40.83 Million | ▲ +171.6% |
| 2022 | -0.94x | CN¥-26.52 Million | CN¥28.12 Million | CN¥54.64 Million | ▲ +92.0% |
| 2020 | -11.84x | CN¥-117.76 Million | CN¥9.94 Million | CN¥127.70 Million | ▼ -43221.6% |
| 2019 | -0.03x | CN¥-2.57 Million | CN¥93.92 Million | CN¥96.49 Million | ▼ -122.4% |
| 2015 | 0.12x | CN¥5.64 Million | CN¥46.11 Million | CN¥40.47 Million | ▲ +320.5% |
| 2014 | -0.06x | CN¥-1.67 Million | CN¥30.07 Million | CN¥31.73 Million | ▲ +0.4% |
| 2013 | -0.06x | CN¥-1.81 Million | CN¥32.54 Million | CN¥34.35 Million | ▲ +99.6% |
| 2012 | -14.20x | CN¥-38.34 Million | CN¥2.70 Million | CN¥41.04 Million | — |